UV FLU TECHNOLOGIES INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2016-05-24: Form 8-K; Period of report 2016-05-19; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
- 2015-12-18: Form 8-K; Period of report 2015-12-16; Description 3.02 Unregistered Sales of Equity Securities; Details 3.02.
- 2015-11-16: Form 8-K; Period of report 2015-11-13; Description 3.02 Unregistered Sales of Equity Securities; Details 3.02.
- 2014-12-08: Form 8-K; Period of report 2014-12-02; Description 4.01 Changes in Registrant's Certifying Accountant; Details 4.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2016-05-24 | 8-K | 2016-05-19 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) On May 19, 2016, the Board of Directors of UV FLU TECHNOLOGIES, INC. | f52316form8kauditors2016a329.htm |
| 2015-12-18 | 8-K | 2015-12-16 | 3.02 Unregistered Sales of Equity Securities | 3.02 Unregistered Sales of Equity Securities. | f121615form8krestrictedstock.htm |
| 2015-11-16 | 8-K | 2015-11-13 | 3.02 Unregistered Sales of Equity Securities | 3.02 Unregistered Sales of Equity Securities. | f111615form8krestrictedstock.htm |
| 2014-12-08 | 8-K | 2014-12-02 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (a) On December 2, 2014, the Board of Directors of UV FLU TECHNOLOGIES, INC. | v396067_8k.htm |
| 2014-10-16 | 8-K | 2014-10-13 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders | 5.03 (a) On October 15, 2014, UV Flu Technologies (“UV Flu”) amended its Articles of Incorporation to increase its number of shares of authorized stock from 75,000,000 to 150,000,000. 5.07 (a) By Written Consent, holders of a majority of shares of common stock of UV Flu approved the amendment to the Articles of Incorporation to increase the number of shares from 75,000,000 to 150,000,000. | v391515_8-k.htm |
| 2014-06-20 | 8-K | 2014-06-17 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 (a) On June 17, 2014, the Board of Directors (the “Board”) of UV Flu Technologies (“UV Flu”) agreed to amend and restate the Bylaws of UV Flu (the “Amended and Restated Bylaws”), effective immediately. | v381800_8-k.htm |
| 2013-10-29 | 8-K | 2013-10-23 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (a) (b) On October 23, 2013, John J. (“Jack”) Lennon resigned as a Director and President/CEO and CFO of the Company and from any and all other positions with the Company. | v358533_8k.htm |
| 2013-04-15 | 8-K | 2013-04-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (a) (b) On April 12, 2013, Dennis Rosen resigned as a Director of the Company and from any and all other positions with the Company. | v341484_8k.htm |
| 2013-04-08 | 8-K | 2013-04-04 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (a) (b) On April 4, 2013, Mr. Glenn Bushee joined the Board of UV Flu Technologies. | v340800_8k.htm |
| 2013-03-01 | 8-K | 2013-02-27 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 (a) (b) On February 27, 2013, Roger Nelsen resigned as a Director of the Company and as Secretary of the Company. | v336799_8k.htm |
| 2012-10-02 | 8-K | 2012-10-02 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 Amendments to Articles of Incorporation and Bylaws; Change in Fiscal year. | v324901_8k.htm |
| 2012-01-20 | 8-K | 2012-01-20 | 8.01 Other Events | 8.01 On January 20, 2012, the Company announced that the one-for-four reverse stock split will take effect at the open of business on January 20, 2012. | v245833_8k.htm |
| 2011-06-27 | 8-K/A | 2011-06-23 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 Amendments to Articles of Incorporation and Bylaws; Change in Fiscal year. | v227138_8ka.htm |
| 2011-06-24 | 8-K | 2011-03-01 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 Amendments to Articles of Incorporation and Bylaws; Change in Fiscal year. | v226979_8k.htm |
| 2011-03-07 | 8-K | 2011-03-01 | 3.02 Unregistered Sales of Equity Securities | 3.02 On March 1, 2011, the Company entered into agreements to issue 9,946,198 shares of its common stock at a price of $0.07 per share in unregistered sales to investors. | v213809_8k.htm |
| 2011-02-08 | 8-K/A | 2011-01-24 | 9.01 Financial Statements and Exhibits | 9.01 (a) Financial Statements of Business Acquired. | v210450_8ka.htm |
| 2011-01-28 | 8-K | 2011-01-24 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 2.01 On January 24, 2011, the Company entered into and completed its acquisition of RxAir pursuant to the Acquisition Agreement. 3.02 As described in Item 2.01, on January 24, 2011, upon the closing of the Company’s acquisition of RxAir, the Company issued 1,500,000 shares of its common stock to Red Oak as partial consideration for the acquisition of RxAir and 75,0000 shares to each of Manny Marquez, Melanie Paschal and John Bugg. | v209362_8k.htm |
| 2011-01-04 | 8-K | 2010-12-31 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On December 31, 2010, Mr. Glenn Bushee resigned as a Director of UV Flu Technologies, Inc. (the “Company”). | v207195_8k.htm |
| 2010-10-29 | 8-K | 2010-10-28 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | v200369_8k.htm |
| 2010-05-28 | 8-K | 2010-05-26 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | v186862_8k.htm | |
| 2010-04-19 | 8-K/A | 2009-12-23 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (i) On December 21, 2009, Bateman & Co., Inc., P.C. (“Bateman”) was dismissed as UV Flu Technologies, Inc.’s (the “Company”) independent registered public accounting firm. | v181476_8ka.htm |
| 2010-01-21 | 8-K/A | 2010-01-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 6, 2010, Mr. John J. Lennon resigned as Secretary of the Company. | v171942_8ka.htm |
| 2010-01-11 | 8-K | 2010-01-11 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On January 6, 2010, the Board of Directors of UV Flu Technologies, Inc. (the “Company”) appointed Dr. Dennis J. Rosen, M.D., FAAP and Mr. Roger Nelsen to the Board of Directors of the Company. | v171009_8k.htm |
| 2009-12-23 | 8-K | 2009-12-23 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (i) On December 21, 2009, Bateman & Co., Inc., P.C. (“Bateman”) was dismissed as UV Flu Technologies, Inc.’s (the “Company”) independent registered public accounting firm. | v168977_8k.htm |
| 2009-12-18 | 8-K | 2009-12-18 | 1.01 Entry into a Material Definitive Agreement | 1.01 On December 16, 2009, UV Flu Technologies, Inc., a Nevada corporation (the “Company”) entered into an Asset Purchase Agreement with AmAirpure, Inc., a Nevada corporation (“Seller”) with an effective date of November 15, 2009 (the “Agreement”), whereby the Company will acquire certain of the assets of Seller relating to the design, development, manufacture, sale and distribution of technology and products including air purification systems (the “Assets”). | v169388_8k.htm |
| 2009-12-10 | 8-K | 2009-12-10 | 8.01 Other Events | 8.01 On December 10, 2009, the Board of Directors of UV Flu Technologies, Inc. (the “Company”) adopted a Code of Ethical Conduct for the Company (the “Ethical Code”). | v168714_8k.htm |
| 2009-11-12 | 8-K | 2009-11-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 5.02 On November 12, 2009, Ms. Sharon Dusza resigned as Director and Ms. Barbara Ceretzke, resigned as Director, President, Chief Executive Officer, Chief Financial Officer and Secretary of Northwest Chariots, Inc. (the “Company”). 5.03 As a result of the name change, the Company’s new trading symbol under the OTC Bulletin Board is “UVFT” effective November 12, 2009. 8.01 On November 12, 2009, the Company effected a 32 for 1 forward stock split of all of its issued and outstanding shares of common stock. | v165874_8k.htm |
| 2009-08-28 | 8-K | 2009-08-26 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On August 26, 2009, Mr. Douglas Dewar resigned as President, Chief Executive Officer and as a member of the Board of Directors of Northwest Chariots Incorporated. | form8k.htm |
| 2008-09-18 | 8-K | 2008-09-15 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8-kdtd09152008.htm | |
| 2008-09-10 | 8-K | 2008-09-08 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | form8-kdtd09032008.htm |